Acid Reducer Tablet, Delayed Release
Product Images NDC 0536-1322

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acid Reducer (NDC 0536-1322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (20 mg (14 Tablet Bottle))

The text is a description of Omeprazole, which is a delayed-release tablet used to treat frequent heartburn. It gives tips on managing heartburn and warns against overdosing. The text provides the active ingredient, dosage instructions, and possible side effects. It also cautions against using the medication in certain conditions, recommends consulting a doctor before usage, and keeping it out of children's reach.*

FDA Label Image

Package Label-principal Display Panel (20 mg Container Carton Label)

This is a drug facts label for Omeprazole delayed-release tablets, manufactured by AstraZenega Pharmaceuticals LP, and distributed by Rugby Laboratories. It includes directions for use, precautions for managing heartburn symptoms, and warnings about potential side effects. The label also includes the active ingredient, storage information, and a barcode.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.